Adam Calarese, MD
Vascular Surgery · Surprise, AZNPI 1821330440
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,874 of the $14,922 with a category attached, or 72.9%. 34 manufacturers reported payments, led by Medtronic at 31.0% of the total.
Across 180 payments — averaging $82.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Endologix LLC$2K
- W. L. Gore & Associates, Inc.$1K
- Shockwave Medical, Inc$1K
- Dilon Technologies, Inc.$749
- Bard Peripheral Vascular, Inc.$708
- plus $5K from 28 others
What the payments were for
- Consulting fees$5003%
- Grants$3,00020%
- Travel & lodging$1431%
- Food & beverage$10,87473%
- Education$4043%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 32 | $4,631 |
| Endologix LLC | 12 | $1,693 |
| W. L. Gore & Associates, Inc. | 14 | $1,033 |
| Shockwave Medical, Inc | 13 | $1,029 |
| Dilon Technologies, Inc. | 6 | $749 |
| Bard Peripheral Vascular, Inc. | 6 | $708 |
| Davol Inc. | 5 | $654 |
| Bolton Medical Inc | 15 | $614 |
| Penumbra, Inc. | 4 | $528 |
| Boston Scientific | 9 | $391 |
| Angiodynamics, Inc. | 4 | $361 |
| Axogen | 3 | $265 |
| Cook Medical LLC | 10 | $249 |
| AbbVie | 2 | $226 |
| Philips North America LLC | 6 | $208 |
| Edwards Lifesciences | 2 | $200 |
| Balt USA, LLC | 3 | $194 |
| Silk Road Medical, Inc. | 3 | $154 |
| Mentor Worldwide LLC | 1 | $143 |
| Johnson & Johnson(2 entities) | 6 | $132 |
| Biom'up France SAS | 1 | $121 |
| Stryker | 1 | $111 |
| Biotronik Inc. | 2 | $103 |
| Inari Medical, Inc. | 4 | $94 |
| Getinge USA Sales, LLC | 2 | $86 |
| Baxter Healthcare | 4 | $66 |
| Lemaitre Vascular, Inc. | 3 | $54 |
| Mozarc Medical US LLC | 1 | $35 |
| Mimedx Group, Inc. | 1 | $17 |
| Reflow Medical Inc | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Artivion, Inc. | 1 | $16 |
| Advanced Oxygen Therapy Inc. | 1 | $14 |
| Cardiovascular Systems Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Endurant$3,290
- Torus Stent Graft System$888
- ENDOCROSS Device$888
- HemoBlast Bellows$720
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$657
- Phasix Mesh$595
- ENDURANT IIS$539
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$537
- TREO ABDOMINAL STENT-GRAFT SYSTEM$490
- AFX2 Bifurcated Endograft System$391
- Auryon Laser System 100-120 Vac$264
- Ovation iX Iliac Stent Graft$246
- Indigo System$236
- NATRELLE SALINE-FILLED BREAST IMPLANTS$226
- Alto Abdominal Stent Graft System$191
- Penumbra System$176
- TurboHawk$175
- SAPIEN 3 Ultra RESILIA$166
- Valiant Captivia$161
- AVANCE NERVE GRAFT$150
How this compares
$14,922 in reported general payments places this provider in the 70th percentile of 105 vascular surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 66 | $58,971 |
| EliquisApixaban | 55 | $42,872 |
| ClopidogrelClopidogrel Bisulfate | 223 | $2,015 |
| Atorvastatin Calcium | 132 | $1,079 |
| Cilostazol | 52 | $966 |
| Enoxaparin Sodium | 14 | $494 |
| Gabapentin | 30 | $271 |
| Rosuvastatin Calcium | 11 | $114 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $60 |
| Diazepam | 31 | $36 |
| Prednisone | 12 | $11 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $132 | $58,97166 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 105 vascular surgery providers in Arizona.
Other vascular surgery in Surprise
- Stephen SmithSurprise$49K
- Marc EckhauserSurprise$45K
- Venkatesh RamaiahScottsdale$452K
- Jeromy BrinkPhoenix$392K
- Luis LeonPhoenix$185K
- Hammad AmerMesa$169K
- Baljeet UppalSun City$166K
- Scott BermanTuscon$150K
- Martin ZomayaPhoenix$139K
- Joshua BaldermanTucson$135K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.